Saeid Tamadoni Jahromi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Saeid Tamadoni Jahromi has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Noora Barzkar
Higher Institution Centre of Excellence, Borneo Marine Research Institute, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia
8 shared publications - Olga Babich
Immanuel Kant Baltic Federal University
4 shared publications - Stanislav Sukhikh
Institute of Living Systems, Immanuel Kant Baltic Federal University, A. Nevskogo Street 14, 236016 Kaliningrad, Russia
4 shared publications Mohsen Gozari
Persian Gulf and Oman Sea Ecology Research Center, Iranian Fisheries Sciences Research Institute, Agricultural Research Education and Extension Organization (AREEO), Bandar Abbas, Iran
3 shared publications- Muhammad Sohail
Department of Microbiology, University of Karachi, Karachi, Pakistan
3 shared publications - Fabio Vianello
Department of Comparative Biomedicine and Food Science, University of Padua, viale dell’Università 16, 35020 Legnaro, Italy
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 20535
Allelopathic effects of Padina sp. and Sargassum sp. as biological control agents of harmful algal blooms (HABs) in the Persian Gulf and Gulf of Oman
Harmful algal blooms (HABs) pose serious threats to coastal ecosystems, public health, and local economies. This study explores the potential of two native macroalgal genera, Padina sp. and Sargassum sp., collected from the Persian Gulf (Bandar Abbas) and the Gulf of Oman (Chabahar), as biological control agents against Cochlodinium polykrikoides. Species identification was achieved through morphological observations and DNA barcoding (rbcL and psbA), ensuring accurate classification despite overlapping traits. Methanolic extracts of Padina (sp. A and sp. C) and Sargassum (sp. B and sp. D) strains inhibited C. polykrikoides, with Padina sp. A showing the strongest activity (LC₅₀ = 122.2 µg/mL) and Sargassum sp. D the weakest (LC₅₀ = 371.2 µg/mL). Fractionation and identification of the most active extracts using thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) revealed the presence of terpenoid and phenolic functional groups in the active fractions of Padina sp. A and Sargassum sp. B, respectively. These extracts exhibited negligible effects on non-target microalgae (Chlorella vulgaris, Isochrysis galbana) at concentrations > 1 mg/mL, shrimp larvae (Litopenaeus vannamei), and human endothelial cells (HUVEC), highlighting their selectivity and safety. These findings demonstrate that Padina and Sargassum produce bioactive compounds capable of selectively suppressing harmful microalgae, underscoring their promise as environmentally compatible agents for managing HABs in marine and aquaculture systems.
- 1 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 20535
Open AccessAllelopathic effects of Padina sp. and Sargassum sp. as biological control agents of harmful algal blooms (HABs) in the Persian Gulf and Gulf of Oman
Harmful algal blooms (HABs) pose serious threats to coastal ecosystems, public health, and local economies. This study explores the potential of two native macroalgal genera, Padina sp. and Sargassum sp., collected from the Persian Gulf (Bandar Abbas) and the Gulf of Oman (Chabahar), as biological control agents against Cochlodinium polykrikoides. Species identification was achieved through morphological observations and DNA barcoding (rbcL and psbA), ensuring accurate classification despite overlapping traits. Methanolic extracts of Padina (sp. A and sp. C) and Sargassum (sp. B and sp. D) strains inhibited C. polykrikoides, with Padina sp. A showing the strongest activity (LC₅₀ = 122.2 µg/mL) and Sargassum sp. D the weakest (LC₅₀ = 371.2 µg/mL). Fractionation and identification of the most active extracts using thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) revealed the presence of terpenoid and phenolic functional groups in the active fractions of Padina sp. A and Sargassum sp. B, respectively. These extracts exhibited negligible effects on non-target microalgae (Chlorella vulgaris, Isochrysis galbana) at concentrations > 1 mg/mL, shrimp larvae (Litopenaeus vannamei), and human endothelial cells (HUVEC), highlighting their selectivity and safety. These findings demonstrate that Padina and Sargassum produce bioactive compounds capable of selectively suppressing harmful microalgae, underscoring their promise as environmentally compatible agents for managing HABs in marine and aquaculture systems.
- Open Access
- 28 September 2023
- Published by Frontiers Media SA in Frontiers in Marine Science
- Vol. 10, 1245077
Marine collagen: purification, properties and application
Collagens are abundant structural proteins found in connective tissues such as bones, swim bladder, skin, blood vessels, intestines, and cartilage. They make up around 30% of the total protein. The purpose of this paper is to provide a summary of the current knowledge about collagen isolated from marine organisms and its possible applications. Collagen is widely used in pharmaceuticals, food, biomedical and cosmetic industries due to its cell adhesion, biocompatibility, and safety properties. This review discusses various methods for extracting collagen from marine vertebrates and its physicochemical properties. Enzymatic extractions might be a more effective at extracting collagen than acidic extractions. Peptides derived from collagen hydrolysates have biological activity that promotes health and relieves symptoms caused by chronic diseases. Aquaculture can help with collagen availability but an integrated technology for processing raw materials is necessary to address the negative effects of production waste. Marine collagen has many benefits over terrestrial sources including its versatility in healing skin damage and slowing down the aging process. The advantages of marine collagen over terrestrial sources are discussed along with its potential biotherapeutic applications in bone and skin injuries. The development of effective cosmetic products can become a strategic direction for technological development.
- 28 September 2023
- Published by Frontiers Media SA in Frontiers in Marine Science
- Vol. 10, 1245077
Open AccessMarine collagen: purification, properties and application
Collagens are abundant structural proteins found in connective tissues such as bones, swim bladder, skin, blood vessels, intestines, and cartilage. They make up around 30% of the total protein. The purpose of this paper is to provide a summary of the current knowledge about collagen isolated from marine organisms and its possible applications. Collagen is widely used in pharmaceuticals, food, biomedical and cosmetic industries due to its cell adhesion, biocompatibility, and safety properties. This review discusses various methods for extracting collagen from marine vertebrates and its physicochemical properties. Enzymatic extractions might be a more effective at extracting collagen than acidic extractions. Peptides derived from collagen hydrolysates have biological activity that promotes health and relieves symptoms caused by chronic diseases. Aquaculture can help with collagen availability but an integrated technology for processing raw materials is necessary to address the negative effects of production waste. Marine collagen has many benefits over terrestrial sources including its versatility in healing skin damage and slowing down the aging process. The advantages of marine collagen over terrestrial sources are discussed along with its potential biotherapeutic applications in bone and skin injuries. The development of effective cosmetic products can become a strategic direction for technological development.
- Open Access
Marine Bacterial Dextranases: Fundamentals and Applications
Dextran, a renewable hydrophilic polysaccharide, is nontoxic, highly stable but intrinsically biodegradable. The α-1, 6 glycosidic bonds in dextran are attacked by dextranase (E.C. 3.2.1.11) which is an inducible enzyme. Dextranase finds many applications such as, in sugar industry, in the production of human plasma substitutes, and for the treatment and prevention of dental plaque. Currently, dextranases are obtained from terrestrial fungi which have longer duration for production but not very tolerant to environmental conditions and have safety concerns. Marine bacteria have been proposed as an alternative source of these enzymes and can provide prospects to overcome these issues. Indeed, marine bacterial dextranases are reportedly more effective and suitable for dental caries prevention and treatment. Here, we focused on properties of dextran, properties of dextran—hydrolyzing enzymes, particularly from marine sources and the biochemical features of these enzymes. Lastly the potential use of these marine bacterial dextranase to remove dental plaque has been discussed. The review covers dextranase-producing bacteria isolated from shrimp, fish, algae, sea slit, and sea water, as well as from macro- and micro fungi and other microorganisms. It is common knowledge that dextranase is used in the sugar industry; produced as a result of hydrolysis by dextranase and have prebiotic properties which influence the consistency and texture of food products. In medicine, dextranases are used to make blood substitutes. In addition, dextranase is used to produce low molecular weight dextran and cytotoxic dextran. Furthermore, dextranase is used to enhance antibiotic activity in endocarditis. It has been established that dextranase from marine bacteria is the most preferable for removing plaque, as it has a high enzymatic activity. This study lays the groundwork for the future design and development of different oral care products, based on enzymes derived from marine bacteria.
Open AccessMarine Bacterial Dextranases: Fundamentals and Applications
Dextran, a renewable hydrophilic polysaccharide, is nontoxic, highly stable but intrinsically biodegradable. The α-1, 6 glycosidic bonds in dextran are attacked by dextranase (E.C. 3.2.1.11) which is an inducible enzyme. Dextranase finds many applications such as, in sugar industry, in the production of human plasma substitutes, and for the treatment and prevention of dental plaque. Currently, dextranases are obtained from terrestrial fungi which have longer duration for production but not very tolerant to environmental conditions and have safety concerns. Marine bacteria have been proposed as an alternative source of these enzymes and can provide prospects to overcome these issues. Indeed, marine bacterial dextranases are reportedly more effective and suitable for dental caries prevention and treatment. Here, we focused on properties of dextran, properties of dextran—hydrolyzing enzymes, particularly from marine sources and the biochemical features of these enzymes. Lastly the potential use of these marine bacterial dextranase to remove dental plaque has been discussed. The review covers dextranase-producing bacteria isolated from shrimp, fish, algae, sea slit, and sea water, as well as from macro- and micro fungi and other microorganisms. It is common knowledge that dextranase is used in the sugar industry; produced as a result of hydrolysis by dextranase and have prebiotic properties which influence the consistency and texture of food products. In medicine, dextranases are used to make blood substitutes. In addition, dextranase is used to produce low molecular weight dextran and cytotoxic dextran. Furthermore, dextranase is used to enhance antibiotic activity in endocarditis. It has been established that dextranase from marine bacteria is the most preferable for removing plaque, as it has a high enzymatic activity. This study lays the groundwork for the future design and development of different oral care products, based on enzymes derived from marine bacteria.
- Open Access
Cellulolytic and Xylanolytic Enzymes from Yeasts: Properties and Industrial Applications
Lignocellulose, the main component of plant cell walls, comprises polyaromatic lignin and fermentable materials, cellulose and hemicellulose. It is a plentiful and renewable feedstock for chemicals and energy. It can serve as a raw material for the production of various value-added products, including cellulase and xylanase. Cellulase is essentially required in lignocellulose-based biorefineries and is applied in many commercial processes. Likewise, xylanases are industrially important enzymes applied in papermaking and in the manufacture of prebiotics and pharmaceuticals. Owing to the widespread application of these enzymes, many prokaryotes and eukaryotes have been exploited to produce cellulase and xylanases in good yields, yet yeasts have rarely been explored for their plant-cell-wall-degrading activities. This review is focused on summarizing reports about cellulolytic and xylanolytic yeasts, their properties, and their biotechnological applications.
Open AccessCellulolytic and Xylanolytic Enzymes from Yeasts: Properties and Industrial Applications
Lignocellulose, the main component of plant cell walls, comprises polyaromatic lignin and fermentable materials, cellulose and hemicellulose. It is a plentiful and renewable feedstock for chemicals and energy. It can serve as a raw material for the production of various value-added products, including cellulase and xylanase. Cellulase is essentially required in lignocellulose-based biorefineries and is applied in many commercial processes. Likewise, xylanases are industrially important enzymes applied in papermaking and in the manufacture of prebiotics and pharmaceuticals. Owing to the widespread application of these enzymes, many prokaryotes and eukaryotes have been exploited to produce cellulase and xylanases in good yields, yet yeasts have rarely been explored for their plant-cell-wall-degrading activities. This review is focused on summarizing reports about cellulolytic and xylanolytic yeasts, their properties, and their biotechnological applications.
- Open Access
Alginate Lyases from Marine Bacteria: An Enzyme Ocean for Sustainable Future
The cell wall of brown algae contains alginate as a major constituent. This anionic polymer is a composite of β-d-mannuronate (M) and α-l-guluronate (G). Alginate can be degraded into oligosaccharides; both the polymer and its products exhibit antioxidative, antimicrobial, and immunomodulatory activities and, hence, find many commercial applications. Alginate is attacked by various enzymes, collectively termed alginate lyases, that degrade glycosidic bonds through β-elimination. Considering the abundance of brown algae in marine ecosystems, alginate is an important source of nutrients for marine organisms, and therefore, alginate lyases play a significant role in marine carbon recycling. Various marine microorganisms, particularly those that thrive in association with brown algae, have been reported as producers of alginate lyases. Conceivably, the marine-derived alginate lyases demonstrate salt tolerance, and many are activated in the presence of salts and, therefore, find applications in the food industry. Therefore, this review summarizes the structural and biochemical features of marine bacterial alginate lyases along with their applications. This comprehensive information can aid in the expansion of future prospects of alginate lyases.
Open AccessAlginate Lyases from Marine Bacteria: An Enzyme Ocean for Sustainable Future
The cell wall of brown algae contains alginate as a major constituent. This anionic polymer is a composite of β-d-mannuronate (M) and α-l-guluronate (G). Alginate can be degraded into oligosaccharides; both the polymer and its products exhibit antioxidative, antimicrobial, and immunomodulatory activities and, hence, find many commercial applications. Alginate is attacked by various enzymes, collectively termed alginate lyases, that degrade glycosidic bonds through β-elimination. Considering the abundance of brown algae in marine ecosystems, alginate is an important source of nutrients for marine organisms, and therefore, alginate lyases play a significant role in marine carbon recycling. Various marine microorganisms, particularly those that thrive in association with brown algae, have been reported as producers of alginate lyases. Conceivably, the marine-derived alginate lyases demonstrate salt tolerance, and many are activated in the presence of salts and, therefore, find applications in the food industry. Therefore, this review summarizes the structural and biochemical features of marine bacterial alginate lyases along with their applications. This comprehensive information can aid in the expansion of future prospects of alginate lyases.
- Open Access
- 2 January 2022
- Published by MDPI AG in Marine Drugs
- Vol. 20 (1) , 46
Marine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity
Cardiovascular diseases (CVDs) have emerged as a major threat to global health resulting in a decrease in life expectancy with respect to humans. Thrombosis is one of the foremost causes of CVDs, and it is characterized by the unwanted formation of fibrin clots. Recently, microbial fibrinolytic enzymes due to their specific features have gained much more attention than conventional thrombolytic agents for the treatment of thrombosis. Marine microorganisms including bacteria and microalgae have the significant ability to produce fibrinolytic enzymes with improved pharmacological properties and lesser side effects and, hence, are considered as prospective candidates for large scale production of these enzymes. There are no studies that have evaluated the fibrinolytic potential of marine fungal-derived enzymes. The current review presents an outline regarding isolation sources, production, features, and thrombolytic potential of fibrinolytic biocatalysts from marine microorganisms identified so far.
- 2 January 2022
- Published by MDPI AG in Marine Drugs
- Vol. 20 (1) , 46
Open AccessMarine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity
Cardiovascular diseases (CVDs) have emerged as a major threat to global health resulting in a decrease in life expectancy with respect to humans. Thrombosis is one of the foremost causes of CVDs, and it is characterized by the unwanted formation of fibrin clots. Recently, microbial fibrinolytic enzymes due to their specific features have gained much more attention than conventional thrombolytic agents for the treatment of thrombosis. Marine microorganisms including bacteria and microalgae have the significant ability to produce fibrinolytic enzymes with improved pharmacological properties and lesser side effects and, hence, are considered as prospective candidates for large scale production of these enzymes. There are no studies that have evaluated the fibrinolytic potential of marine fungal-derived enzymes. The current review presents an outline regarding isolation sources, production, features, and thrombolytic potential of fibrinolytic biocatalysts from marine microorganisms identified so far.
- 1 January 2021
- Vol. 20 (1) , 157-178
Population genetics of Penaeus semisulcatus from Persian Gulf and Oman Sea using newly developed DNA microsatellite markers
- 1 January 2021
- Vol. 20 (1) , 157-178
Population genetics of Penaeus semisulcatus from Persian Gulf and Oman Sea using newly developed DNA microsatellite markers
- 4 September 2020
- Published by Springer Nature in Fisheries Science
- Vol. 86 (6) , 1055-1065
Evaluation of hemolymph biochemical properties, clearance rate, bacterial microbiota and expression of HSP genes of gulf pearl oyster Pinctada radiata in response to salinity changes
- 4 September 2020
- Published by Springer Nature in Fisheries Science
- Vol. 86 (6) , 1055-1065
Evaluation of hemolymph biochemical properties, clearance rate, bacterial microbiota and expression of HSP genes of gulf pearl oyster Pinctada radiata in response to salinity changes
- Open Access
- 8 August 2019
- Published by MDPI AG in Marine Drugs
- Vol. 17 (8) , 464
Metabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology
Marine organisms produce a large array of natural products with relevance in drug discovery. These compounds have biological activities such as antioxidant, antibacterial, antitumor, antivirus, anticoagulant, anti-inflammatory, antihypertensive, antidiabetic, and so forth. Consequently, several of the metabolites have made it to the advanced stages of clinical trials, and a few of them are commercially available. In this review, novel information on natural products isolated from marine microorganisms, microalgae, and macroalgae are presented. Given due research impetus, these marine metabolites might emerge as a new wave of promising drugs.
- 8 August 2019
- Published by MDPI AG in Marine Drugs
- Vol. 17 (8) , 464
Open AccessMetabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology
Marine organisms produce a large array of natural products with relevance in drug discovery. These compounds have biological activities such as antioxidant, antibacterial, antitumor, antivirus, anticoagulant, anti-inflammatory, antihypertensive, antidiabetic, and so forth. Consequently, several of the metabolites have made it to the advanced stages of clinical trials, and a few of them are commercially available. In this review, novel information on natural products isolated from marine microorganisms, microalgae, and macroalgae are presented. Given due research impetus, these marine metabolites might emerge as a new wave of promising drugs.